Silence Therapeutics (SLN) Cash & Current Investments (2019 - 2025)
Historic Cash & Current Investments for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $122.4 million.
- Silence Therapeutics' Cash & Current Investments rose 5200.97% to $122.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.4 million, marking a year-over-year increase of 5200.97%. This contributed to the annual value of $147.3 million for FY2024, which is 11970.25% up from last year.
- As of Q3 2025, Silence Therapeutics' Cash & Current Investments stood at $122.4 million, which was up 5200.97% from $186.6 million recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' Cash & Current Investments peaked at $208.1 million during Q1 2025, and registered a low of $37.2 million during Q2 2023.
- Over the past 5 years, Silence Therapeutics' median Cash & Current Investments value was $98.5 million (recorded in 2021), while the average stood at $102.0 million.
- As far as peak fluctuations go, Silence Therapeutics' Cash & Current Investments soared by 67688.26% in 2021, and later crashed by 4272.79% in 2023.
- Silence Therapeutics' Cash & Current Investments (Quarter) stood at $99.1 million in 2021, then plummeted by 35.14% to $64.3 million in 2022, then grew by 4.3% to $67.1 million in 2023, then surged by 119.7% to $147.3 million in 2024, then decreased by 16.95% to $122.4 million in 2025.
- Its Cash & Current Investments stands at $122.4 million for Q3 2025, versus $186.6 million for Q2 2025 and $208.1 million for Q1 2025.